Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

Due to financial, logistical, and regulatory barriers, only two in 10 patients eligible for CAR T-cell therapy in the US ...

TURKU, FI / ACCESS Newswire / May 30, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Phase I study shows promising clinical activity and tolerability of bexmarilimab plus standard-of-care in ...

Making CAR T Vision a reality will require the coming together of a complex ecosystem of partners, each with their own unique role to play. To learn more about CAR T Vision, review the roadmap report ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results ...

Intermountain Health is now offering a national first-of-its kind expansion of CAR-T Cell Therapy, bringing cutting-edge cancer care closer to patients in ...

A compound found in nearly every energy drink may also be feeding aggressive blood cancers. Researchers discovered that leukemia cells absorb taurine to grow faster — and extra taurine only made ...

Though new cases of leukemia are being detected among the young, around 80 to 90 per cent of the children are able to defeat ...

CAR T cell immunotherapy, which uses a patient's own modified immune cells to find and destroy cancer cells, can produce ...

"Are you nervous?" Coltin asked son Reace. "I'm not nervous, really," he answered. "Why?" "Cause I'm here to save you." ...